依诺肝素用于机械心脏瓣膜患者长期抗凝成功一例
本文报告一例机械主动脉瓣置换术后因华法林禁忌而改用依诺肝素长期抗凝的患者。患者初始按体重给药后出现左大腿血肿需手术清除,后根据抗Xa因子峰值水平(目标0.6-1.0 IU/ml)调整剂量,随后13年无血栓栓塞、瓣膜功能障碍、出血并发症或重大不良反应。提示依诺肝素或可用于华法林不可行的机械瓣患者,但需精细监测抗Xa因子并调整剂量。
要点
- 华法林仍是机械瓣膜患者指南推荐的血栓预防用药。
- 依诺肝素按体重给药后出现血肿,提示需监测抗Xa因子调整剂量。
- 抗Xa因子峰值目标0.6-1.0 IU/ml,调整后13年无血栓或出血事件。
核心结论
- 依诺肝素可能作为华法林禁忌的机械瓣膜患者的长期抗凝替代方案。
- 精细监测抗Xa因子水平并调整剂量是治疗成功的关键。
研究设计与样本
- 个案报道:一例机械主动脉瓣患者因华法林禁忌接受依诺肝素长期抗凝。
主要发现
- 初始按体重给药1个月后出现左大腿血肿,需手术清除。
- 改为依据抗Xa因子峰值(目标0.6-1.0 IU/ml)调整剂量后,13年内无血栓栓塞、瓣膜功能障碍、出血并发症或重大不良反应。
关键数值与推荐
- 抗Xa因子峰值目标范围为0.6-1.0 IU/ml。
临床怎么用
- 对华法林不可行的机械瓣患者,可考虑依诺肝素并依据抗Xa因子峰值调整剂量。
- 需警惕初始按体重给药时的出血风险,及时监测抗Xa因子。
局限性
- 仅为单例个案报道,证据级别有限。
- 原文未报告长期随访中依诺肝素的具体剂量调整细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thromboembolism related to a mechanical heart valve (MHV) is a major complication after surgical valve replacement. Warfarin remains as guideline-endorsed thromboprophylaxis in patients with MHVs. Alternative anticoagulation therapy for patients who do not tolerate or who fail warfarin is not adequately covered in the current guidelines. We report a case of successful long-term anticoagulation with enoxaparin in a patient with a mechanical aortic valve who had a contraindication to warfarin. The patient developed a left thigh hematoma requiring surgical evacuation 1 month after initiation of weight-based dosing of enoxaparin. His dose was then titrated based on peak anti-factor Xa levels (goal 0.6-1.0 IU/ml). He remained free of signs and symptoms of thromboembolic events, valve dysfunction, bleeding complications, or major adverse effects from long-term enoxaparin use for the next 13 years. Our case provides promising evidence of the potential role of enoxaparin in patients with MHVs in whom warfarin thromboprophylaxis is not possible. Meticulous monitoring of anti-factor Xa levels and dosage adjustments are crucial to treatment success.
引用
- Wang X, Mathew C, Korapati S, et al. Successful Long-term Anticoagulation with Enoxaparin in a Patient with a Mechanical Heart Valve. Pharmacotherapy. 2020. PMID: 31885093. doi:10.1002/phar.2361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。